Show simple item record

Characterization of two new electrophoretic variants of human triosephosphate isomerase: Stability, kinetic, and immunological properties

dc.contributor.authorMohrenweiser, Harvey W.en_US
dc.contributor.authorAsakawa, Jun-ichien_US
dc.date.accessioned2006-09-11T14:20:47Z
dc.date.available2006-09-11T14:20:47Z
dc.date.issued1982-02en_US
dc.identifier.citationAsakawa, J.; Mohrenweiser, H. W.; (1982). "Characterization of two new electrophoretic variants of human triosephosphate isomerase: Stability, kinetic, and immunological properties." Biochemical Genetics 20 (1-2): 59-76. <http://hdl.handle.net/2027.42/44141>en_US
dc.identifier.issn0006-2928en_US
dc.identifier.issn1573-4927en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44141
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7092803&dopt=citationen_US
dc.description.abstractTwo new electrophoretic variants of human triosephosphate isomerase (TPI) have been partially purified and characterized. The TPI Manchester variant, a cathodally migrating electrophoretic allozyme identified in an individual with the phenotype TPI 1-Manchester, is associated with a normal level of enzyme activity in erythrocytes and normal kinetic properties. It is very thermolabile at 55 and 57° C, although it is not uniquely sensitive to either guanidine-HCl or urea denaturation. The TPI Hiroshima-2 variant is an anodally migrating allozyme (the phenotype of proband is TPI 1-Hiroshima-2) with normal activity and kinetic properties and also normal stability characteristics. It is inactivated less by antisera raised against normal human TPI than either the normal or the Manchester allozyme. Dissociation-reassociation experiments utilizing these allozymes have confirmed that normal human red blood cell TPI isozymes are produced by a sequence of reactions (presumably deamidations) involving alternating subunits.en_US
dc.format.extent884883 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherTriosephosphate Isomeraseen_US
dc.subject.otherHuman Geneticsen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherMedical Microbiologyen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherZoologyen_US
dc.subject.otherVariantsen_US
dc.subject.otherHumanen_US
dc.subject.otherStructural Characteristicsen_US
dc.titleCharacterization of two new electrophoretic variants of human triosephosphate isomerase: Stability, kinetic, and immunological propertiesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelEcology and Evolutionary Biologyen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbsecondlevelNatural Resources and Environmenten_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Human Genetics, University of Michigan Medical School, 48109, Ann Arbor, Michigan; Radiation Effects Research Foundation, 730, Hiroshima, Japanen_US
dc.contributor.affiliationumDepartment of Human Genetics, University of Michigan Medical School, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid7092803en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44141/1/10528_2004_Article_BF00484936.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00484936en_US
dc.identifier.sourceBiochemical Geneticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.